3% Diquafosol tetrasodium

DRUG4 trials

Sponsors

He Eye Hospital

Conditions

Diabetic Eye ProblemsDry Eye

Unknown Phase

Diquafosol Ophthalmic Solution for Dry Eye Symptoms

He Eye HospitalDiabetic Eye Problems

Start: 2023-03-03End: 2023-11-01Target: 101Updated: 2023-01-12

Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye

He Eye HospitalDiabetic Eye Problems

Start: 2023-04-01End: 2023-11-01Target: 70Updated: 2022-12-12

Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye

CompletedNCT05682547

He Eye HospitalDiabetic Eye Problems

Start: 2022-12-01End: 2023-06-30Updated: 2025-07-25

Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye

Not yet recruitingNCT06537349

He Eye HospitalDry Eye

Start: 2024-08-15End: 2024-12-31Target: 30Updated: 2024-08-12

Related Papers

The Impact of 3% Diquafosol Ophthalmic Solution on Tear Film and Corneal Nerve Density in Patients with Diabetes and Dry Eye Disease: A Randomized Controlled Study

Ophthalmology and Therapy2025-08-21

Effects of Diquafosol Sodium Ophthalmic Solution on Tear Film Matrix Metallopeptidase-9 and Corneal Nerve Density in Patients with Type 2 Diabetic Dry Eye

Journal of Ocular Pharmacology and Therapeutics2023-12-157 citations

A protocol for a single center, randomized, controlled trial comparing the clinical efficacy of 3% diquafosol and 0.1% hyaluronic acid in diabetic patients with dry eye disease.

2023-12-121 citations

Relationship between ocular surface pain and corneal nerve loss in dry eye diabetics: a cross-sectional study in Shenyang, China

BMJ Open2023-09-0114 citations

Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study

Journal of Ocular Pharmacology and Therapeutics2022-01-2031 citations